{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T18:04:44Z","timestamp":1781028284382,"version":"3.54.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0014396","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["IV-111-PP-14, IV-112-PP-18, IV-113-PP-20, and IV-114-PP-19"],"award-info":[{"award-number":["IV-111-PP-14, IV-112-PP-18, IV-113-PP-20, and IV-114-PP-19"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Coxsackievirus A10 (CVA10) infection primarily causes hand, foot, and mouth diseases (HFMD) in children. As CVA10 is one of the most widespread enteroviruses, the development of a CVA10 vaccine is essential. It could also be used to create a multivalent vaccine for preventing HFMD alongside other enteroviruses. Most clinical isolates of CVA10 are difficult to propagate in Vero cells, while only a few pre-screened CVA10 clones could. In this study, we have successfully isolated a highly Vero cell-adapted CVA10 strain (CVA10-V) from the parental CVA10. After propagation of CVA10-V in Vero cells, the purified full-particle (F-particle) of CVA10-V could induce strong immunogenicity in mice model, while the empty-particle of CVA10-V did not. The CVA10-V F-particle were mixed with EV-A71 bulk for immunization and a good neutralization response to each virus were observed. In this study, a RD-propagated CVA10 strain (CVA10-R) was not unable to infect Vero cells. Five amino acid variations of P1 protein (470, 664, 705, 792, and 804) were noted between the CVA10-V and CVA10-R. Infectious clones with single-site mutation representing these five locations were constructed to investigate the effects of these variations on Vero infectivity. Substitution of D from E at position VP1\u2013141 (P1-705) was found to be the critical determinant for CVA10-V infection of Vero cells. Variation at this position was found to affect CVA10\u2019s ability to attach to Vero cells. Our study pinpoints the critical sites of viral P1 protein that render the Vero-adaptation and this Vero-adapted CVA10-V strain would be beneficial for multivalent HFMD vaccine development using the Vero cell culture system.<\/jats:p>","DOI":"10.1371\/journal.pntd.0014396","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:37:39Z","timestamp":1780421859000},"page":"e0014396","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["VP1\u2013141 is a determinant of a Vero cell-adapted Coxsackievirus A10 for vaccine development"],"prefix":"10.1371","volume":"20","author":[{"given":"Chi-Hsun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yeu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Ren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suh-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-0389","authenticated-orcid":true,"given":"Chia-Chyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"4","key":"pntd.0014396.ref001","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/14787210.2019.1585242","article-title":"Hand, foot, and mouth disease associated with coxsackievirus A10: More serious than it seems","volume":"17","author":"L Bian","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"12","key":"pntd.0014396.ref002","article-title":"Circulation of coxsackievirus A10 and A6 in hand-foot-mouth disease in China, 2009-2011","volume":"7","author":"QB Lu","year":"2012","journal-title":"PLoS One"},{"issue":"47","key":"pntd.0014396.ref003","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1016\/j.vaccine.2014.08.064","article-title":"Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases","volume":"32","author":"C-C Liu","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"pntd.0014396.ref004","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1080\/21645515.2015.1049780","article-title":"Is a multivalent hand, foot, and mouth disease vaccine feasible","volume":"11","author":"M Klein","year":"2015","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"pntd.0014396.ref005","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/jmv.24151","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: Outbreaks of coxsackieviruses A10","volume":"87","author":"Q Yang","year":"2015","journal-title":"J Med Virol"},{"issue":"20","key":"pntd.0014396.ref006","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.3390\/ijms20205201","article-title":"Enterovirus-associated hand-foot and mouth disease and neurological complications in Japan and the rest of the world","volume":"20","author":"G Gonzalez","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"pntd.0014396.ref007","article-title":"Clinical, etiological and epidemiological investigations of hand, foot and mouth disease in southern Vietnam during 2015 - 2018","volume":"14","author":"LNT Nhan","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0014396.ref008","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/22221751.2021.1899772","article-title":"The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China","volume":"10","author":"H Jiang","year":"2021","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"pntd.0014396.ref009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1089\/vim.2020.0073","article-title":"Seroprevalence of neutralizing antibodies against candidate serotypes of enterovirus vaccines among Korean children","volume":"34","author":"S Kim","year":"2021","journal-title":"Viral Immunol"},{"issue":"2","key":"pntd.0014396.ref010","article-title":"An epidemiological surveillance of hand foot and mouth disease in paediatric patients and in community: A Singapore retrospective cohort study, 2013-2018","volume":"15","author":"N Min","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0014396.ref011","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jmv.27268","article-title":"Characterization of coxsackievirus A10 strains isolated from children with hand, foot, and mouth disease","volume":"94","author":"J Zhang","year":"2022","journal-title":"J Med Virol"},{"key":"pntd.0014396.ref012","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.02.008","article-title":"Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles","volume":"129","author":"C-C Liu","year":"2016","journal-title":"Antiviral Res"},{"issue":"24","key":"pntd.0014396.ref013","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1016\/j.vaccine.2018.05.005","article-title":"The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease","volume":"36","author":"H Lim","year":"2018","journal-title":"Vaccine"},{"issue":"9","key":"pntd.0014396.ref014","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/14760584.2018.1510326","article-title":"Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease","volume":"17","author":"C-Y Fang","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"pntd.0014396.ref015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17460441.2021.1965987","article-title":"Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies","volume":"17","author":"C-Y Fang","year":"2022","journal-title":"Expert Opin Drug Discov"},{"issue":"11","key":"pntd.0014396.ref016","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis and control of enterovirus 71","volume":"10","author":"T Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pntd.0014396.ref017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41579-018-0005-4","article-title":"The life cycle of non-polio enteroviruses and how to target it","volume":"16","author":"J Baggen","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"pntd.0014396.ref018","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00705-019-04520-6","article-title":"Recommendations for the nomenclature of enteroviruses and rhinoviruses","volume":"165","author":"P Simmonds","year":"2020","journal-title":"Arch Virol"},{"issue":"5","key":"pntd.0014396.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2018.03.019","article-title":"KREMEN1 is a host entry receptor for a major group of enteroviruses","volume":"23","author":"J Staring","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"1","key":"pntd.0014396.ref020","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1038\/s41467-018-07531-0","article-title":"Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating","volume":"9","author":"L Zhu","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"pntd.0014396.ref021","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41467-019-13936-2","article-title":"Hand-foot-and-mouth disease virus receptor KREMEN1 binds the canyon of Coxsackie Virus A10","volume":"11","author":"Y Zhao","year":"2020","journal-title":"Nat Commun"},{"issue":"31","key":"pntd.0014396.ref022","doi-asserted-by":"crossref","first-page":"18711","DOI":"10.1073\/pnas.2005341117","article-title":"Molecular basis of Coxsackievirus A10 entry using the two-in-one attachment and uncoating receptor KRM1","volume":"117","author":"Y Cui","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"41","key":"pntd.0014396.ref023","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1016\/j.vaccine.2016.08.033","article-title":"Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge","volume":"34","author":"C Shen","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"pntd.0014396.ref024","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1002\/jmv.27796","article-title":"Comparative analysis of the biological characteristics of three CV-A10 clones adaptively cultured on Vero cells","volume":"94","author":"H Zhao","year":"2022","journal-title":"J Med Virol"},{"issue":"1","key":"pntd.0014396.ref025","article-title":"Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice","volume":"12","author":"H-H An","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"pntd.0014396.ref026","doi-asserted-by":"crossref","first-page":"199101","DOI":"10.1016\/j.virusres.2023.199101","article-title":"Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system","volume":"329","author":"S-C Lien","year":"2023","journal-title":"Virus Res"},{"issue":"2","key":"pntd.0014396.ref027","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"E Domingo","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"pntd.0014396.ref028","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"A-H Chou","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"pntd.0014396.ref029","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"C-C Liu","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"pntd.0014396.ref030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jmii.2023.10.006","article-title":"The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage","volume":"56","author":"Y-S Shen","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"pntd.0014396.ref031","doi-asserted-by":"crossref","first-page":"100559","DOI":"10.1016\/j.jvacx.2024.100559","article-title":"Enhanced production of recombinant coxsackievirus A16 using a serum-free HEK293A suspension culture system for bivalent enterovirus vaccine development","volume":"20","author":"Y-A Chen","year":"2024","journal-title":"Vaccine X"},{"key":"pntd.0014396.ref032","article-title":"Early viral entry assays for the identification and evaluation of antiviral compounds","volume":"105","author":"CJ Tai","year":"2015","journal-title":"J Vis Exp"},{"issue":"7","key":"pntd.0014396.ref033","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JCM.00007-11","article-title":"Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A","volume":"49","author":"YF Hu","year":"2011","journal-title":"J Clin Microbiol"},{"key":"pntd.0014396.ref034","doi-asserted-by":"crossref","first-page":"112212","DOI":"10.1016\/j.biopha.2021.112212","article-title":"Proliferation characteristics of coxsackievirus A10 in mice and immune protection ability of experimental inactivated vaccine","volume":"143","author":"W Gao","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"pntd.0014396.ref035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jviromet.2010.03.001","article-title":"Epidemiologic features and virus isolation of enteroviruses in Northern Taiwan during 2000-2008","volume":"165","author":"K-C Tsao","year":"2010","journal-title":"J Virol Methods"},{"key":"pntd.0014396.ref036","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/S0264-410X(02)00182-2","article-title":"Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate","volume":"20","author":"Y-C Lin","year":"2002","journal-title":"Vaccine"},{"key":"pntd.0014396.ref037","doi-asserted-by":"crossref","first-page":"127314","DOI":"10.1016\/j.vaccine.2025.127314","article-title":"Development and characterization of MRC-5 and Vero cell-adapted enterovirus D68 strains for vaccine production","volume":"60","author":"K Senpuku","year":"2025","journal-title":"Vaccine"},{"issue":"7","key":"pntd.0014396.ref038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003511","article-title":"Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction","volume":"9","author":"Y Nishimura","year":"2013","journal-title":"PLoS Pathog"},{"issue":"6","key":"pntd.0014396.ref039","article-title":"A single amino acid mutation in VP1 of coxsackievirus A6 determining efficiency of VP0 cleavage and proliferation","volume":"99","author":"Y Sun","year":"2025","journal-title":"J Virol"},{"issue":"4","key":"pntd.0014396.ref040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/v15040932","article-title":"Human SCARB2 Acts as a Cellular Associator for Helping Coxsackieviruses A10 Infection","volume":"15","author":"S-L Yu","year":"2023","journal-title":"Viruses"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0014396","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:42:07Z","timestamp":1781026927000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014396"}},"subtitle":[],"editor":[{"given":"Joshua","family":"Anzinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014396","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}